Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a Phase 2a randomized, double-blind, placebo-controlled study designed to assess the safety and tolerability of an investigational monoclonal antibody, VIS410, in subjects with uncomplicated influenza.
Epistemonikos ID: 9aea4eb5184737c6914fa5ebbb95073a77da4ab1
First added on: May 20, 2024